In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...

A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...

AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

The Downtown Amarillo Library will be temporarily closed for Wednesday evening and Thursday due to a city water main issue.

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

Sep. 10, 2024 — A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease ...